Observational Study
Copyright ©The Author(s) 2020.
World J Clin Cases. Aug 26, 2020; 8(16): 3503-3514
Published online Aug 26, 2020. doi: 10.12998/wjcc.v8.i16.3503
Table 1 Dilatation times in esophageal carcinoma patients repeatedly undergoing dilation for esophageal stenosis
Achieved marked effect
Cumulative percentageDid not achieve significant results
nPercentage (%)nPercentage (%)
1 time32.862.8610297.14
2 times65.888.579694.12
3 times4344.7949.525355.21
4 times59.4354.294890.57
5 times1837.5071.433062.50
6 times1756.6787.621343.33
Table 2 Dilatation effect in esophageal carcinoma patients repeatedly undergoing dilation for esophageal stenosis
1st time (n = 105)2nd time (n = 102)3rd time (n = 96)4th time (n = 53)5th time (n = 48)6th time (n = 30)7th time (n = 13)F/P value
R1 (mm)5.16 ± 1.675.65 ± 0.996.37 ± 0.676.99 ± 1.187.27 ± 2.107.85 ± 2.748.21 ± 3.4134.71/0.01a
R2 (mm)12.06 ± 2.9212.27 ± 2.1312.24 ± 1.6912.62 ± 1.4412.65 ± 2.3913.27 ± 1.6313.97 ± 2.1116.95/0.00a
R2-R1 (mm)6.90 ± 1.036.62 ± 0.995.87 ± 1.545.63 ± 0.895.38 ± 1.415.42 ± 1.105.76 ± 0.843.29/0.00a
Table 3 Symptom distress score (mean ± SD) of esophageal cancer patients who underwent repeated dilation for esophageal stenosis
After the 1st dilation (n = 105)After the 2nd dilation (n = 102)After the 3rd dilation (n = 96)After the 4th dilation (n = 53)After the 5th dilation (n = 48)After the 6th dilation (n = 30)After the 7th dilation (n = 13)F/P value
Total score185.49 ± 15.04190.62 ± 14.83189.11 ± 12.76191.37 ± 14.20193.55 ± 12.37192.17 ± 15.10194.04 ± 11.2138.97/0.00a
Symptom dimension106.37 ± 8.79111.08 ± 5.99108.39 ± 4.11110.35 ± 8.37114.70 ± 6.81110.24 ± 7.28112.33 ± 9.1014.24/0.00a
Distress dimension79.12 ± 2.6679.54 ± 1.0980.72 ± 1.3781.02 ± 1.5778.85 ± 1.9881.93 ± 2.1981.71 ± 6.6817.64/0.00a
Table 4 Symptom incidence and item score in esophageal carcinoma patients repeatedly undergoing dilation for esophageal stenosis
After the 1st dilation (n = 105)After the 2nd dilation (n = 102)After the 3rd dilation (n = 96)After the 4th dilation (n = 53)After the 5th dilation (n = 48)After the 6th dilation (n = 30)After the 7th dilation (n = 13)
Item%mean ± SDItem%mean ± SDItem%mean ± SDItem%mean ± SDItem%mean ± SDItem%mean ± SDItem%mean ± SD
Dysphagia63.26.4 ± 1.8Dysphagia58.96.2 ± 1.6Dysphagia69.16.7 ± 2.4Distress78.47.3 ± 2.6Sadness77.47.5 ± 3.1Cough78.17.3 ± 1.9Sadness79.67.9 ± 2.8
Pain61.15.8 ± 2.3Cough56.66.1 ± 2.3Weight loss69.37.1 ± 1.8Dysphagia70.66.9 ± 3.1Cough73.96.6 ± 2.4Sadness77.57.3 ± 2.6Fatigue707.1 ± 1.7
Distress57.36.1 ± 2.1Pain51.26.6 ± 1.4Pain67.96.8 ± 2.1Fatigue68.37.6 ± 2.2Weight loss70.17.1 ± 3.6Fatigue73.17.6 ± 2.7Weight loss69.56.9 ± 2.4
Table 5 Distress incidence and item score in esophageal carcinoma patients repeatedly undergoing dilation for esophageal stenosis
After the 1st dilation (n = 105)After the 2nd dilation (n = 102)After the 3rd dilation (n = 96)After the 4th dilation (n = 53)After the 5th dilation (n = 48)After the 6th dilation (n = 30)After the 7th dilation (n = 13)
Item%mean ± SDItem%mean ± SDItem%mean ± SDItem%mean ± SDItem%mean ± SDItem%mean ± SDItem%mean ± SD
Work49.34.7 ± 1.1Work56.74.8 ± 1.4Emotion56.24.7 ± 2.3Emotion57.35.1 ± 2.4Life fun49.64.7 ± 2.2Life fun51.45.2 ± 3.0General activities54.85.2 ± 2.4
Emotion494.2 ± 1.2Emotion52.54.6 ± 2.2General activities40.64.2 ± 1.6Life fun40.74.5 ± 1.82 Emotion48.14.9 ± 1.3General activities37.25.0 ± 2.9Emotion43.75.3 ± 1.7
General activities32.13.8 ± 0.9Life fun50.93.9 ± 1.7Life fun37.34.1 ± 2.0General activities40.74.1 ± 2.33 General activities31.74.9 ± 2.4Emotion374.9 ± 1.8Life fun42.93.9 ± 1.1
Table 6 Correlation between symptom distress and dilatation effect in esophageal carcinoma patients repeatedly undergoing dilation for esophageal stenosis (r)
Symptom distress after the 1st dilation (n = 105)Symptom distress after the 2nd dilation (n = 102)Symptom distress after the 3rd dilation (n = 96)Symptom distress after the 4th dilation (n = 53)Symptom distress after the 5th dilation (n = 48)Symptom distress after the 6th dilation (n = 30)Symptom distress after the 7th dilation (n = 13)
R2-R1-0.356a-0.332a-0.665a-0.157a-0.675a-0.293b-0.273a
R2-0.185a-0.257a-0.392a-0.366a-0.119-0.665a-0.227a
Table 7 Correlation between symptom distress and severity of esophageal restenosis in esophageal carcinoma patients repeatedly undergoing dilation for esophageal stenosis (r)
Symptom distress after the 1st dilation (n = 105)Symptom distress after the 2nd dilation (n = 102)Symptom distress after the 3rd dilation (n = 96)Symptom distress after the 4th dilation (n = 53)Symptom distress after the 5th dilation (n = 48)Symptom distress after the 6th dilation (n = 30)
R120.304b-0.306a-0.311b-0.565b-0.198-0.278